Betsy Nabel, MD - World Medical Innovation Forum
WMIF Main Site
Betsy Nabel
This speaker appears at this event:

Betsy Nabel, MD

President, Brigham Health

Professor of Medicine, HMS

Elizabeth G. Nabel, president of the Harvard University-affiliated Brigham Health and professor of medicine at Harvard Medical School since 2010, ranks among academic medicine’s most respected leaders. Also a gifted biomedical researcher and wellness advocate, she made history with her 1997 appointment as the first woman chief of cardiology at the University of Michigan. A native of St. Paul, Minnesota, Dr. Nabel earned a B.A. degree (1974) from St. Olaf College, an M.D. (1981) from Weill Cornel Medical College in New York City, and completed her internal medicine and cardiology training at Brigham and Women’s Hospital. As head of Brigham Health, she is responsible for patient care, research, education, and community missions at Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital, and the Brigham and Women’s Physician Organization. She also leads Brigham Health’s $1.5 billion life-giving breakthroughs campaign. Dr. Nabel joined U-M’s Medical School faculty in 1987 and became director of the Cardiovascular Research Center in 1992. She has made substantial contributions to the understanding of the molecular genetics of cardiovascular diseases, including clarifying fundamental processes of cell division and growth of vascular smooth muscle cells in blood vessels. The author of more than 250 scientific articles, she holds 17 patents, co-edited two books on coronary artery disease, and has served on several journal editorial boards. In 1999, she was appointed scientific director of the National Heart, Lung, and Blood Institute (NHLBI), where she established a research study for genes related to chronic diseases, including cardiovascular, as part of the long-running Framingham Heart Study. As NHLBI’s director from 2006 to 2009, Dr. Nabel leveraged a $3 billion research portfolio to establish pioneering programs in genomics and stem cells, stem and progenitor cell biology, and translational research. She also launched the Red Dress Heart Truth campaign to raise heart awareness in women and advocated in Congress for increased biomedical research funding. Dr. Nabel is co-founder of the Global Alliance for Chronic Diseases, an alliance of health research institutions that support research and outreach activities to treat and prevent chronic non-communicable diseases in developing countries. In 2015, the National Football League appointed her its first chief medical adviser. Dr. Nabel serves on the boards of Ariadne Labs, the Boys & Girls Club of Boston, the Broad Institute, and Moderna Therapeutics, and previously served on the Howard Hughes Medical Institute Medical Advisory Board. She is a member of the American Academy of Arts and Sciences, the American Society for Clinical Investigation, the Association of American Physicians (AAP), the National Academy of Medicine, and a fellow of the American Association for the Advancement of Science. Among other honors, she is the recipient of the Greater Boston Chamber of Commerce Distinguished Bostonian Award, the AAP George M. Kober Medal, and several American Heart Association awards.

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA